@article{3b920e04a5d0494997765ca52cb6ef62,
title = "Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough?",
abstract = "In a multicenter, observational, propensity-score-weighted cohort of 249 adults with uncomplicated Pseudomonas aeruginosa bacteremia, patients receiving short-course (median, 9 days; interquartile range [IQR], 8-10) therapy had a similar odds of recurrent infection or death within 30 days as those receiving longer courses (median, 16 days; IQR, 14-17).",
keywords = "Pseudomonas aeruginosa, cefepime, gram-negative bacteremia, piperacillin-tazobactam, treatment duration",
author = "Valeria Fabre and Joe Amoah and Cosgrove, {Sara E.} and Tamma, {Pranita D.}",
note = "Funding Information: Financial support. This work was supported by the US Food and Drug Administration (FDA) under award HHSF223201610070C (P. D. T.). The reported findings represent the position of the authors and not necessarily that of the FDA. Funding Information: This work was supported by the US Food and Drug Administration (FDA) under award HHSF223201610070C (P. D. T.). The reported findings represent the position of the authors and not necessarily that of the FDA. Publisher Copyright: {\textcopyright} 2019 The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.",
year = "2019",
month = nov,
day = "13",
doi = "10.1093/cid/ciz223",
language = "English (US)",
volume = "69",
pages = "2011--2014",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "11",
}